EP2783219A1 — Methods for determining the susceptibility of a virus to an attachment inhibitor
Assigned to Bristol Myers Squibb Co · Expires 2014-10-01 · 12y expired
What this patent protects
The present invention provides novel compositions and methods that can be used for determining the susceptibility of a virus to an attachment inhibitor. The present invention also provides methods for predicting whether an infected individual will respond to treatment with an att…
USPTO Abstract
The present invention provides novel compositions and methods that can be used for determining the susceptibility of a virus to an attachment inhibitor. The present invention also provides methods for predicting whether an infected individual will respond to treatment with an attachment inhibitor, thereby allowing an effective treatment regimen to be designed without subjecting the patient to unnecessary side effects.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.